Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
6. References
Della Corte, L., Crichton, R. R., Duburs, G., Nolan, K., Tipton, K. F., Tirzitis, G., and Ward, R. J., 2002, The use of taurine analogues to investigate taurine functions and their potential therapeutic applications, Amino Acids 23:367–379.
Fernandes, M. A. S., Santos, M. S., Vicente, J. A. F., Moreno, A. J. M., Velena, A., Duburs, G., and Oliveira, C., 2003, Effects of 1,4-dihydropyridine derivatives (cerebrocrast, gammapyrone, glutapyrone, and diethone) on mitochondrial bioenergetics and oxidative stress: a comparative study, Mitochondrion 3:47–59.
Fujimoto, S., Katsuki, H., Kume, T., Kaneko, S., and Akaike, A., 2004, Mechanisms of oxygen glucose deprivation-induced glutamate release from cerebrocortical slice cultures, Neurosci. Res. 50:179–187.
Gallo, V., Ciotti, M. T., Coletti, A., Aloisi, F., and Levi, G., 1982, Selective release of glutamate from cerebellar granule cells differentiating in culture, Proc. Natl. Acad. Sci. USA 79:7919–7923.
Goldberg, M. P. and Choi, D. W., 1993, Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury, J. Neurosci. 8:3510–3524.
Kalda, A. and Zharkovsky, A., 1999, Metabotropic glutamate receptor agonists protect from oxygen-glucose deprivation-and colchicine-induced apoptosis in primary cultures of cerebellar granule cells, Neuroscience 92:7–14.
Karpova, M., Germane, S., Cebers, G., Pankov, O., Klusa, V., Duburs, G., and Bisenieks E., 1993, [The anticonvulsant properties of glutapyrone, a new type of derivative of amino acid-containing 1,4-dihydropyridines], Biull. Eksp. Biol. Med. 116:283–286 (in Russian).
Kimura, M., Sawada, K., Miyagawa, T., Kuwada, M., Katayama, K., and Nishizawa, Y., 1998, Role of glutamate receptors and voltage-dependent calcium and sodium channels in the extracellular glutamate/aspartate accumulation and subsequent neuronal injury induced by oxygen/glucose deprivation in cultured hippocampal neurons, J. Pharmacol. Exp. Ther. 285:178–185.
Klegeris, A., Liutkevicius, E., Mikalauskiene, G., Duburs, G., McGeer, P.L., and Klusa, V., 2002, Antiinflammatory effects of cerebrocrast in a model of rat paw oedema and on mononuclear THP-1 cells, Eur. J. Pharmacol. 441:203–208.
Klusa, V., 1995, Cerebrocrast (IOS-1.1212). Neuroprotectant, cognition enhancer. Drugs Future 20: 135–138.
Klusa, V. and Germane, S., 1996, Alcoholized maternal rat offspring: model for testing of physical and psychoemotional neurodeficit, Scand. J. Lab. Animal Sci. 23:403–409.
Kluša, V., Ģērmane, S., and Duburs, G., 1997, Taurine and tauropyrone: anti-neurodeficit activity in alcoholized rats, Pharmacol. Toxicol. 80,Suppl.1:29.
Kluša, V., Vītoliņa, R., Dambrova, M., Atare, Z., Mežapuķe, R., Meirena, D., Bisenieks, E., Duburs, G., and Azzi, A., 1996, The effects of glutapyrone, a glutamate-containing 1,4-dihydropyridine compound, on the cardiovascular system, muscle contraction and protein kinase C activation, Proc. Latvian Acad. Sci. Sect. B 50:108–113.
Kristian, T. and Siesjö, B., K., 1998, Calcium in ischemic cell death, Stroke 29:705–718.
Misane, I., Klusa, V., Dambrova, M., Ģērmane, S., Duburs, G., Bisenieks, Rimondini, E. R., and Ögren, S. O., 1998, Atypical neuromodulatory profile of glutapyrone, a representative of a novel “class” of aminoacid containing dipeptide-mimicking 1,4-dihydropyridine (DHP)compounds in vitro and in vivo studies, Eur. Neuropsychopharmacol. 8:329–347.
Mosmann, T., 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65:55–63.
O’Byrne, M. B. and Tipton, K. F., 2000, Taurine-induced attenuation of MPP+ neurotoxicity in vitro: a possible role for GABAA subclass of GABA receptors. J. Neurochem. 74:2087–2093.
Pedata, F., Latini, S., Pugliese, A. M., and Pepeu, G., 1993, Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions, J. Neurochem. 61:284–289.
Poikans, J., Tirzitis, G., Bisenieks, E., Uldrikis, J., Gurevich, V. S., Mikhailova, I.A., and Duburs, G., 1994, The derivatives of 2,6-dimethyl-1,4-dihydroisonicotinic acid and their antiplatelet properties, Eur. J. Med. Chem. 29:325–328.
Scorziello, A., Pellegrini, C., Forte, L., Tortiglione, A., Gioielli, A., Iossa, S., Amoroso, S., Tufano, R., Di Renzo, G., and Annunziato, L., 2001, Differential vulnerability of cortical and cerebellar neurons in primary culture to oxygen glucose deprivation followed by reoxygenation, J. Neurosci. Res. 63:20–26.
Tarasenko, L. M., Neporada, K. S., and Klusha, V. E., 2002, [Stress-protective effect of glutapyrone belonging to a new type of amino acid-containing 1,4-dihydropyridines on periodontal tissues and stomach in rats with different resistance to stress], Biull. Eksp. Biol. Med. 133:369–371 (in Russian).
Velena, A., Skujins, A., Svirskis, S., Bisenieks, E., Uldrikis, J., Poikans, J., Duburs, G., and Klusa, V., 1997, Modification of swelling-contraction-aggregation processes in rat muscle mitochondria by the 1,4-dihydropyridines, cerebrocrast and glutapyrone, themselves and in the presence of azidothymidine, Cell Biochem. Funct. 15:211–220.
Velly, L. J., Guillet, B. A., Masmejean, F. M., Nieoullon, A. L., Bruder, N. J., Gouin, F. M., and Pisano, P. M., 2003, Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: role of glutamate and its transporters, Anesthesiology 99:368–375.
Yoshioka, A., Yamaya, Y., Saiki, S., Kanemoto, M., Hirose, G., Beesley, J., and Pleasure, D., 2000, Non-N-methyl-D-aspartate glutamate receptors mediate oxygen-glucose deprivation-induced oligodendroglial injury, Brain Res. 854:207–215.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Klusa, V., Klimaviciusa, L., Duburs, G., Poikans, J., Zharkovsky, A. (2006). Anti-Neurotoxic Effects of Tauropyrone, a Taurine Analogue. In: Oja, S.S., Saransaari, P. (eds) Taurine 6. Advances in Experimental Medicine and Biology, vol 583. Springer, Boston, MA . https://doi.org/10.1007/978-0-387-33504-9_56
Download citation
DOI: https://doi.org/10.1007/978-0-387-33504-9_56
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32356-5
Online ISBN: 978-0-387-33504-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)